Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Diphtheria toxoid 30 iu/tetanus toxoid 40 iu/acellular pertussis toxoid 25 micrograms/inactivated poliomyelitis 0.5mL prefilled syringe |
Is a |
Diphtheria + tetanus + pertussis + inactivated poliovirus vaccine |
false |
Inferred relationship |
Some |
|
|
Diphtheria toxoid 30 iu/tetanus toxoid 40 iu/acellular pertussis toxoid 25 micrograms/inactivated poliomyelitis 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Diphtheria vaccine |
false |
Inferred relationship |
Some |
|
|
Diphtheria toxoid 30 iu/tetanus toxoid 40 iu/acellular pertussis toxoid 25 micrograms/inactivated poliomyelitis 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Pertussis vaccine |
false |
Inferred relationship |
Some |
|
|
Diphtheria toxoid 30 iu/tetanus toxoid 40 iu/acellular pertussis toxoid 25 micrograms/inactivated poliomyelitis 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Tetanus toxoid |
false |
Inferred relationship |
Some |
|
|
Diphtheria toxoid 30 iu/tetanus toxoid 40 iu/acellular pertussis toxoid 25 micrograms/inactivated poliomyelitis 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Inactivated Poliovirus vaccine |
false |
Inferred relationship |
Some |
|
|
Diphtheria toxoid 30 iu/tetanus toxoid 40 iu/acellular pertussis toxoid 25 micrograms/inactivated poliomyelitis 0.5mL prefilled syringe |
Has manufactured dose form |
Injection |
false |
Inferred relationship |
Some |
|
|
Diphtheria toxoid 30 iu/tetanus toxoid 40 iu/acellular pertussis toxoid 25 micrograms/inactivated poliomyelitis 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Diphtheria toxoid |
false |
Inferred relationship |
Some |
|
|
Diphtheria toxoid 30 iu/tetanus toxoid 40 iu/acellular pertussis toxoid 25 micrograms/inactivated poliomyelitis 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Tetanus vaccine |
false |
Inferred relationship |
Some |
|
|
Diphtheria toxoid 30 iu/tetanus toxoid 40 iu/acellular pertussis toxoid 25 micrograms/inactivated poliomyelitis 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Diphtheria vaccine |
false |
Inferred relationship |
Some |
|
|
Diphtheria toxoid 30 iu/tetanus toxoid 40 iu/acellular pertussis toxoid 25 micrograms/inactivated poliomyelitis 0.5mL prefilled syringe |
Is a |
Product manufactured as parenteral dose form (product) |
false |
Inferred relationship |
Some |
|
|